Apellis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. T…
Biotechnology
US, Waltham [HQ]
APLS/Financials
Segments · Problems · Premarket · Compliance

Segment Analysis

Segment Analysis
Revenue · By Business Segment
Not available for APLS
Revenue · By Area
Not available for APLS
End of APLS's Analysis
CIK: 1492422 CUSIP: 03753U106 ISIN: US03753U1060 LEI: - UEI: -
Secondary Listings
APLS has no secondary listings inside our databases.